Skip to main content
SpringerLink
Log in

Influence of chronic naloxone treatment on development of hypertension in the spontaneously hypertensive rat

  • Short Communication
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Chronic administration of naloxone by means of miniosmotic pumps retarded the development of hypertension in young spontaneously hypertensive rats (SHRs) in a dose-related manner. Abrupt termination of naloxone treatment resulted in acceleration in the rate of the blood pressure increase, while increasing the naloxone concentration further slowed the development of hypertension in SHRs. The heart rates of SHRs undergoing chronic naloxone treatment were generally lower than those of control SHRs. Naloxone had no influence upon the mean systeolic blood pressures or heart rates of normotensive Wistar-Kyoto control rats. These findings indicate that chronic naloxone treatment can alter the development of hypertension in the SHR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Atweh SF, Kuhar MJ (1977) Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res 124:53–67

    Google Scholar 

  • Bellet M, Elghozi JL, Meyer P, Pernollet MG, Schmitt H (1980) Central cardiovascular effects of narcotic analgesics and enkephalins in rats. Br J Pharmacol 71:365–369

    Google Scholar 

  • Bellet M, Elghozi JL, Meyer P (1981) Central hypotensive effect of diprenorphine in normotensive rat and SHR. Arch Int Pharmacodyn 252:147–151

    Google Scholar 

  • deJong W, Petty MA, Sitsen JMA (1983) Role of opioid peptides in brain mechanisms regulating blood pressure. Chest 83 [Suppl 2]: 306–308

    Google Scholar 

  • Delbarre B, Casset-Senon D, Delbarre G, Sestillange P, Christin O (1982) Naloxone effects on blood pressure, analgesia and diuresis in spontaneously hypertensive and normotensive rats. Neurosci Lett 30:167–172

    Google Scholar 

  • Evans AGJ, Nasmyth PA, Stewart HC (1952) The fall of blood pressure caused by intravenous morphine in the rat and the cat. Br J Pharmacol 7:542–552

    Google Scholar 

  • Hahn EF, Martucci CP (1982) Early exposure to naloxone increases blood pressure in normotensive and hypertensive rats. Biochem Biophys Res Comm 107:707–713

    Google Scholar 

  • Hökfelt T, Elde R, Johanson O, Terenius L, Stein L (1977) The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system. Neurosci Lett 5:25–31

    Google Scholar 

  • Holaday JW (1983a) Cardiovascular effects of endogenous opiate systems. Ann Rev Pharmacol Toxicol 23:541–594

    Google Scholar 

  • Holaday JW (1983b) Cardiovascular consequences of endogenous opiate antagonism. Biochem Pharmacol 32:573–585

    Google Scholar 

  • Judy WV, Watanabe AM, Henry DP, Besch HR Jr, Murphy WE, Hockel GM (1976) Sympathetic nerve activity: Role in regulation of blood pressure in the spontaneously hypertensive rat. Circ Res 38 [Suppl 2]:21–29

    Google Scholar 

  • Laubie M, Schmitt H, Vincent M, Remond G (1977) Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol 46:67–71

    Google Scholar 

  • Martucci CP, Hahn EF (1979) Brain opiate receptor concentrations are increased in adult spontaneously hypertensive rats. Endocr Res Commun 6:291–297

    Google Scholar 

  • Nakamura K, Hayashi T (1982a) Methionine enkephalinergic neuronal activity in cerebral nuclei of spontaneously hypertensive rats. Hypertension 4:662–669

    Google Scholar 

  • Nakamura K, Hayashi T (1982b) Altered methionine enkephalin immunoreactivity in cerebral nuclei of spontaneously hypertensive rats. Clin Exp Hypertens A4:297–301

    Google Scholar 

  • Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 28:282–293

    Google Scholar 

  • Sawynok J, Pinsky C, Labella FS (1979) On the specificity of naloxone as an opiate antagonist. Life Sci 25:1621–1632

    Google Scholar 

  • Strahlendorf JC, Strahlendorf HK, McKown-Pulliam R, Hughes MJ, Lang IM (1982) Chronic administration of naltrexone alters central catecholamine levels but not the development of hypertension in spontaneously hypertensive rats. Neuropharmacology 21:1195–1198

    Google Scholar 

  • Yukimura T, Unger T, Rascher W, Lang RE, Ganten D (1981) Central peptidergic stimulation in blood pressure control: Role of enkephalins in rats. Clin Sci 61:347–350

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Pharmacology and Physiology, Marquette University School of Dentistry, 53233, Milwaukee, WI, USA

    R. M. Quock, Linda K. Vaughn & F. J. Kouchich

Authors
  1. R. M. Quock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda K. Vaughn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. J. Kouchich
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quock, R.M., Vaughn, L.K. & Kouchich, F.J. Influence of chronic naloxone treatment on development of hypertension in the spontaneously hypertensive rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 325, 88–90 (1984). https://doi.org/10.1007/BF00507060

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00507060

Key words

Search

Navigation